vs
ARK RESTAURANTS CORP（ARKR）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
ARK RESTAURANTS CORP的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.1倍（$40.7M vs $35.5M），ARK RESTAURANTS CORP净利率更高（2.2% vs -304.2%，领先306.4%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -9.4%），ARK RESTAURANTS CORP自由现金流更多（$-1.8M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -1.8%）
ARK餐饮集团在美国多州运营数十家不同定位的餐饮门店，覆盖休闲正餐、快休闲餐饮及高端精致料理赛道，提供美式家常餐、烧烤、海鲜及意式美食，服务当地社区居民及往来游客。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
ARKR vs RXRX — 直观对比
营收规模更大
ARKR
是对方的1.1倍
$35.5M
营收增速更快
RXRX
高出691.2%
-9.4%
净利率更高
ARKR
高出306.4%
-304.2%
自由现金流更多
ARKR
多$45.5M
$-47.3M
两年增速更快
RXRX
近两年复合增速
-1.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $40.7M | $35.5M |
| 净利润 | $896.0K | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 2.7% | -304.8% |
| 净利率 | 2.2% | -304.2% |
| 营收同比 | -9.4% | 681.7% |
| 净利润同比 | -71.7% | 39.6% |
| 每股收益（稀释后） | $0.25 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARKRRXRX
| Q4 25 | $40.7M | $35.5M | ||
| Q3 25 | $37.3M | $5.2M | ||
| Q2 25 | $43.7M | $19.2M | ||
| Q1 25 | $39.7M | $14.7M | ||
| Q4 24 | $45.0M | $4.5M | ||
| Q3 24 | $43.4M | $26.1M | ||
| Q2 24 | $50.4M | $14.4M | ||
| Q1 24 | $42.3M | $13.8M |
净利润ARKRRXRX
| Q4 25 | $896.0K | $-108.1M | ||
| Q3 25 | $-1.9M | $-162.3M | ||
| Q2 25 | $-3.5M | $-171.9M | ||
| Q1 25 | $-9.3M | $-202.5M | ||
| Q4 24 | $3.2M | $-178.9M | ||
| Q3 24 | $-4.5M | $-95.8M | ||
| Q2 24 | $640.0K | $-97.5M | ||
| Q1 24 | $-1.4M | $-91.4M |
毛利率ARKRRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率ARKRRXRX
| Q4 25 | 2.7% | -304.8% | ||
| Q3 25 | -4.6% | -3327.6% | ||
| Q2 25 | -7.8% | -916.8% | ||
| Q1 25 | -11.6% | -1297.9% | ||
| Q4 24 | 12.6% | -4042.4% | ||
| Q3 24 | -12.7% | -377.1% | ||
| Q2 24 | 1.6% | -697.4% | ||
| Q1 24 | -2.8% | -698.4% |
净利率ARKRRXRX
| Q4 25 | 2.2% | -304.2% | ||
| Q3 25 | -5.1% | -3135.3% | ||
| Q2 25 | -7.9% | -894.2% | ||
| Q1 25 | -23.3% | -1373.3% | ||
| Q4 24 | 7.0% | -3935.5% | ||
| Q3 24 | -10.3% | -367.5% | ||
| Q2 24 | 1.3% | -676.6% | ||
| Q1 24 | -3.4% | -662.4% |
每股收益（稀释后）ARKRRXRX
| Q4 25 | $0.25 | $-0.17 | ||
| Q3 25 | $-0.53 | $-0.36 | ||
| Q2 25 | $-0.96 | $-0.41 | ||
| Q1 25 | $-2.57 | $-0.50 | ||
| Q4 24 | $0.88 | $-0.56 | ||
| Q3 24 | $-1.24 | $-0.34 | ||
| Q2 24 | $0.18 | $-0.40 | ||
| Q1 24 | $-0.40 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.1M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $33.7M | $1.1B |
| 总资产 | $130.4M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资ARKRRXRX
| Q4 25 | $9.1M | $743.3M | ||
| Q3 25 | $11.3M | $659.8M | ||
| Q2 25 | $12.3M | $525.1M | ||
| Q1 25 | $11.1M | $500.5M | ||
| Q4 24 | $13.1M | $594.4M | ||
| Q3 24 | $10.3M | $427.6M | ||
| Q2 24 | $11.5M | $474.3M | ||
| Q1 24 | $10.4M | $296.3M |
总债务ARKRRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益ARKRRXRX
| Q4 25 | $33.7M | $1.1B | ||
| Q3 25 | $32.7M | $1.0B | ||
| Q2 25 | $34.7M | $919.1M | ||
| Q1 25 | $38.1M | $933.9M | ||
| Q4 24 | $47.3M | $1.0B | ||
| Q3 24 | $44.1M | $524.6M | ||
| Q2 24 | $48.9M | $584.4M | ||
| Q1 24 | $49.7M | $401.2M |
总资产ARKRRXRX
| Q4 25 | $130.4M | $1.5B | ||
| Q3 25 | $133.5M | $1.4B | ||
| Q2 25 | $136.3M | $1.3B | ||
| Q1 25 | $141.9M | $1.3B | ||
| Q4 24 | $154.6M | $1.4B | ||
| Q3 24 | $156.0M | $726.5M | ||
| Q2 24 | $166.5M | $775.9M | ||
| Q1 24 | $169.6M | $557.8M |
负债/权益比ARKRRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-550.0K | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $-47.3M |
| 自由现金流率自由现金流/营收 | -4.4% | -133.1% |
| 资本支出强度资本支出/营收 | 3.1% | 3.5% |
| 现金转化率经营现金流/净利润 | -0.61× | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流ARKRRXRX
| Q4 25 | $-550.0K | $-46.1M | ||
| Q3 25 | $633.0K | $-117.4M | ||
| Q2 25 | $1.9M | $-76.4M | ||
| Q1 25 | $612.0K | $-132.0M | ||
| Q4 24 | $-1.3M | $-115.4M | ||
| Q3 24 | $728.0K | $-59.2M | ||
| Q2 24 | $3.2M | $-82.2M | ||
| Q1 24 | $208.0K | $-102.3M |
自由现金流ARKRRXRX
| Q4 25 | $-1.8M | $-47.3M | ||
| Q3 25 | $-989.0K | $-117.6M | ||
| Q2 25 | $1.2M | $-79.6M | ||
| Q1 25 | $290.0K | $-133.8M | ||
| Q4 24 | $-2.0M | $-116.7M | ||
| Q3 24 | $-482.0K | $-63.8M | ||
| Q2 24 | $2.5M | $-83.4M | ||
| Q1 24 | $-148.0K | $-109.0M |
自由现金流率ARKRRXRX
| Q4 25 | -4.4% | -133.1% | ||
| Q3 25 | -2.6% | -2272.5% | ||
| Q2 25 | 2.7% | -413.9% | ||
| Q1 25 | 0.7% | -907.4% | ||
| Q4 24 | -4.4% | -2567.7% | ||
| Q3 24 | -1.1% | -244.6% | ||
| Q2 24 | 5.0% | -578.5% | ||
| Q1 24 | -0.4% | -789.9% |
资本支出强度ARKRRXRX
| Q4 25 | 3.1% | 3.5% | ||
| Q3 25 | 4.3% | 4.7% | ||
| Q2 25 | 1.5% | 16.4% | ||
| Q1 25 | 0.8% | 12.4% | ||
| Q4 24 | 1.4% | 28.6% | ||
| Q3 24 | 2.8% | 17.5% | ||
| Q2 24 | 1.2% | 8.2% | ||
| Q1 24 | 0.8% | 48.2% |
现金转化率ARKRRXRX
| Q4 25 | -0.61× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.43× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 4.94× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
